Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
Recruiting · NCT06295770 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Obinutuzumab in Treatment of Fibrillary Glomerulonephritis | Fibrillary Glomerulonephritis | Recruiting | Phase 2 | 2026-04-13 | NCT06295770 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Rochester | United States | 664 |